What's in Dong-A Pharmaceutical Co., Ltd.'s pipeline?

Dong-A Pharmaceutical Co., Ltd. has 7 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 3 in Phase 1.

Which companies overlap with Dong-A Pharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: American University of Beirut Medical Center, Dong-A ST Co., Ltd., Eli Lilly and Company, IBSA Institut Biochimique SA, Pfizer Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dong-a-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Dong-A Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Dong-A Pharmaceutical Co., Ltd. pipeline: 1 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Exforge®	Exforge®	marketed
DA-8159 (Udenafil)	DA-8159 (Udenafil)	phase 3	PDE5 inhibitor	PDE5 (phosphodiesterase type 5)	Urology
r-hCG	r-hCG	phase 3	gonadotropin	LH receptor	Reproductive Health

Therapeutic area mix

Reproductive Health · 1
Urology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

American University of Beirut Medical Center · 1 shared drug class
Dong-A ST Co., Ltd. · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
IBSA Institut Biochimique SA · 1 shared drug class
Pfizer Inc. · 1 shared drug class
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · 1 shared drug class
Regina Elena Cancer Institute · 1 shared drug class
University of California, San Francisco · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Dong-A Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Dong-A Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dong-a-pharmaceutical-co-ltd. Accessed 2026-05-14.